A video-game based cognitive training for breast cancer survivors with cognitive impairment: A prospective randomized pilot trial

by Anne Bellens, Ella Roelant, Bernard Sabbe, Marc Peeters, Peter A. van Dam
Published 2020-10-01

Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey

by Annemie Luyckx, Leen Wyckmans, Anne-Sophie Bonte, Xuan Bich Trinh, Peter A. van Dam
Published 2020-07-01

Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update

by Yannick Verhoeven, Delphine Quatannens, Xuan Bich Trinh, An Wouters, Evelien L.J. Smits, Filip Lardon, Jorrit De Waele, Peter A. van Dam
Published 2021-02-01

Immuno-PET Molecular Imaging of RANKL in Cancer

by Jonatan Dewulf, Christel Vangestel, Yannick Verhoeven, Jorrit De Waele, Karen Zwaenepoel, Peter A. van Dam, Filipe Elvas, Tim Van den Wyngaert
Published 2021-04-01

A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples.

by Melike Marsan, Gert Van den Eynden, Ridha Limame, Patrick Neven, Jan Hauspy, Peter A Van Dam, Ignace Vergote, Luc Y Dirix, Peter B Vermeulen, Steven J Van Laere
Published 2014-01-01

PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

by Sandra Tuyaerts, An M. T. Van Nuffel, Eline Naert, Peter A. Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens, Emiel De Jaeghere, Frédéric Amant, Katrien Vandecasteele, Hannelore Denys
Published 2019-05-01

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review

by Peter A. van Dam, Yannick Verhoeven, Julie Jacobs, An Wouters, Wiebren Tjalma, Filip Lardon, Tim Van den Wyngaert, Jonatan Dewulf, Evelien Smits, Cécile Colpaert, Hans Prenen, Marc Peeters, Martin Lammens, Xuan Bich Trinh
Published 2019-05-01

Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.

by Xuan Bich Trinh, Wiebren A A Tjalma, Luc Y Dirix, Peter B Vermeulen, Dieter J Peeters, Dimcho Bachvarov, Marie Plante, Els M Berns, Jozien Helleman, Steven J Van Laere, Peter A van Dam
Published 2011-01-01

The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemother...

by Christophe Van Berckelaer, Iris Vermeiren, Leonie Vercauteren, Charlotte Rypens, Gizem Oner, Xuan Bich Trinh, Wiebren A. A. Tjalma, Glenn Broeckx, Emmanuelle Charafe-Jauffret, Steven Van Laere, François Bertucci, Cecile Colpaert, Peter A. van Dam
Published 2021-09-01

Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer

by Francesco Schettini, Mario Giuliano, Matteo Lambertini, Rupert Bartsch, David James Pinato, Concetta Elisa Onesti, Nadia Harbeck, Diana Lüftner, Sylvie Rottey, Peter A. van Dam, Khalil Zaman, Giorgio Mustacchi, Joseph Gligorov, Ahmad Awada, Mario Campone, Hans Wildiers, Alessandra Gennari, Vivianne C. G. Tjan-Heijnen, Javier Cortes, Mariavittoria Locci, Ida Paris, Lucia Del Mastro, Sabino De Placido, Miguel Martín, Guy Jerusalem, Sergio Venturini, Giuseppe Curigliano, Daniele Generali
Published 2021-09-01